Welcome to OM Pharma
Immunostimulant - Immunotherapy
Broncho-Vaxom® : Chronic bronchitis - Chronic obstructive pulmonary disease
  Philosophy
  History
  Worldwide activity
  R & D
  Manufacturing
  Products
    Marketing Authorizations
    International Availability
  Main Products
    - Broncho-Vaxom
    - Dicynone
    - Doxium
    - Uro-Vaxom
    Other Products
    - Doxiproct
    - Doxiproct Plus
    - Gynazole
    - Sinomarin
  Health and Diseases
  News
  Contacts
  Careers and jobs
  Forum


  homepage > products broncho-vaxom > limitations for use
   
  Broncho-Vaxom
 
Limitations for use

Contraindications
Known hypersensitivity towards the constituents of Broncho-Vaxom.

Precautions
On the basis of present knowledge, the administration of Broncho-Vaxom to children aged less than 6 months is not recommended, because of the immaturity of their immune system.

Effects on ability to drive and use machines
Broncho-Vaxom is presumed to be safe and unlikely to produce an effect.

Pregnancy and lactation
Reproduction studies in animals have not demonstrated any risk to the fetus, but controlled studies in pregnant women are not available. As regards breast-feeding, no specific studies have been performed and no data have been reported up to now.
  Contact us   back home